Celsee Diagnostics, an innovator of cutting-edge liquid-biopsy products, announced today that PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech and medical device industries, has named Celsee Diagnostics as the Medical Device Company of the Year Trailblazer silver winner.
“It was an honor to receive this award. Improved enumeration and molecular characterization of circulating tumor cells (CTCs) may predict therapeutic response based on a single blood draw for routine clinical testing. The need exists for simple, non-invasive and inexpensive tests for therapy choice and monitoring in oncology diagnostics. Our products are currently available for research use, and we continue to meet our milestones in our paths for CE-IVD marking and FDA 510K clearance to facilitate personalized treatment and improved patient outcomes.This is yet another validation that our simplified microfluidic device and instrument line for enriching and analyzing CTCs is on track,” stated Celsee Diagnostics’ President & CEO Dr. Kalyan Handique.
Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Gold and Silver winners are selected in each of the five Company of the Year categories: Pharma/Biotech Company, Medical Device/Diagnostics Company, Specialty Pharma/Biotech Company, Advertising Agency, and Supplier/Vendor. Winning companies are selected based on their ability to excel in three main aspects: Innovation, talent development and social responsibility.
“Each of our 2016 Company of the Year winners—both Gold and Silver—did far more than just deliver a product to their customers,” says Anna Stashower, CEO and Publisher of PM360. “Developing innovative medicines, technologies, and services to better serve our industry is only a small part of what makes them successful. These companies also shine internally through strong company cultures that are resulting in future leaders and innovative risk-takers as well as undeniable dedication to helping the communities around them through charity work and volunteering.”
In total, 48 winners were honored during a special—and very much enjoyed—sold-out reception at Gotham Hall on September 23rd, 2016, and will be featured in the October issue of PM360.
About Celsee Diagnostics
Celsee Diagnostics, a privately-held Michigan-based company, develops automated systems for rare CTC enrichment and single-cell analysis. The company’s precise, accurate, and reliable platform for research and clinical diagnostics development will allow healthcare professionals more time to focus on their patients’ therapeutic treatment and outcomes. The label-free Celsee PREP platforms perform all the required processing steps to isolate and execute downstream single-cell analysis including immunochemistry, DNA FISH and mRNA FISH, while the Celsee ANALYZER scans and analyzes the prepared slide automatically. For more information, visit www.celsee.com.
PM360 is the premier source for information that product managers and pharma and medical device marketing professionals need to succeed in the complex, ever-changing healthcare environment. PM360 offers invaluable perspective on important industry issues through a full-circle combination of how-to information and thoughtful career insights. The PM360 Trailblazer Awards span five categories, including Company of the Year, Lifetime Achievement, Marketer of the Year, Brand Champion Awards and Initiative Awards. For more information, visit www.pm360online.com.